116 related articles for article (PubMed ID: 36051387)
1. Effects of
Song J; Li N; Hu R; Yu Y; Xu K; Ling H; Lu Q; Yang T; Wang T; Yin X
Front Endocrinol (Lausanne); 2022; 13():949990. PubMed ID: 36051387
[TBL] [Abstract][Full Text] [Related]
2. PPARD rs2016520 (T/C) and NOS1AP rs12742393 (A/C) polymorphisms affect therapeutic efficacy of nateglinide in Chinese patients with type 2 diabetes mellitus.
Wang T; Song JF; Zhou XY; Li CL; Yin XX; Lu Q
BMC Med Genomics; 2021 Nov; 14(1):267. PubMed ID: 34772419
[TBL] [Abstract][Full Text] [Related]
3. PPARD rs2016520 polymorphism affects repaglinide response in Chinese Han patients with type 2 diabetes mellitus.
Song JF; Wang T; Zhu J; Zhou XY; Lu Q; Guo H; Zhang F; Wang Y; Li W; Wang DD; Cui YW; Lv DM; Yin XX
Clin Exp Pharmacol Physiol; 2015 Jan; 42(1):27-32. PubMed ID: 25311380
[TBL] [Abstract][Full Text] [Related]
4. PPARD rs2016520 polymorphism is associated with metabolic traits in a large population of Chinese adults.
Tang L; Lü Q; Cao H; Yang Q; Tong N
Gene; 2016 Jul; 585(2):191-5. PubMed ID: 26915488
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor (PPAR) delta genetic polymorphism and its association with insulin resistance index and fasting plasma glucose concentrations in Chinese subjects.
Hu C; Jia W; Fang Q; Zhang R; Wang C; Lu J; Xiang K
Diabet Med; 2006 Dec; 23(12):1307-12. PubMed ID: 17116180
[TBL] [Abstract][Full Text] [Related]
6. Associations of type 2 diabetes with common variants in PPARD and the modifying effect of vitamin D among middle-aged and elderly Chinese.
Lu L; Wu Y; Qi Q; Liu C; Gan W; Zhu J; Li H; Lin X
PLoS One; 2012; 7(4):e34895. PubMed ID: 22509365
[TBL] [Abstract][Full Text] [Related]
7. A variation in KCNQ1 gene is associated with repaglinide efficacy on insulin resistance in Chinese Type 2 Diabetes Mellitus Patients.
Zhou X; Zhu J; Bao Z; Shang Z; Wang T; Song J; Sun J; Li W; Adelusi TI; Wang Y; Lv D; Lu Q; Yin X
Sci Rep; 2016 Nov; 6():37293. PubMed ID: 27857189
[TBL] [Abstract][Full Text] [Related]
8. GLP-1 receptor agonists stimulate ANGPTL8 production through the PI3K/Akt pathway in a GLP-1 receptor-dependent manner.
Liu J; Yang K; Xiao W; Le Y; Lang S; Zhang J; Wei R; Yang J; Hong T
Peptides; 2018 Aug; 106():83-90. PubMed ID: 30003931
[TBL] [Abstract][Full Text] [Related]
9. PPARD rs2016520 polymorphism and circulating lipid levels connect with brain diseases in Han Chinese and suggest sex-dependent effects.
Huang Y; Nie S; Zhou S; Li K; Sun J; Zhao J; Fei B; Wang Z; Ye H; Hong Q; Gao X; Duan S
Biomed Pharmacother; 2015 Mar; 70():7-11. PubMed ID: 25776471
[TBL] [Abstract][Full Text] [Related]
10. Positive association between PPARD rs2016520 polymorphism and coronary heart disease in a Han Chinese population.
Ye HD; Li YR; Hong QX; Zhou AN; Zhao QL; Xu LM; Xu MQ; Xu XT; Tang LL; Dai DJ; Jiang DJ; Huang Y; Wang DW; Duan SW
Genet Mol Res; 2015 Jun; 14(2):6350-9. PubMed ID: 26125839
[TBL] [Abstract][Full Text] [Related]
11. Association of peroxisome proliferator-activated receptor delta and additional gene-smoking interaction on cardiovascular disease.
Yang W; Mao S; Qu B; Zhang F; Xu Z
Clin Exp Hypertens; 2017; 39(2):114-118. PubMed ID: 28287878
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Biomarkers in Adults with Type 2 Diabetes: The Role of PPAR-γ2 and PPAR-β/δ Polymorphisms.
Reza-López SA; González-Gurrola S; Morales-Morales OO; Moreno-González JG; Rivas-Gómez AM; González-Rodríguez E; Moreno-Brito V; Licón-Trillo A; Leal-Berumen I
Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136661
[TBL] [Abstract][Full Text] [Related]
13. Variation in the peroxisome proliferator-activated receptor delta gene in relation to common metabolic traits in 7,495 middle-aged white people.
Grarup N; Albrechtsen A; Ek J; Borch-Johnsen K; Jørgensen T; Schmitz O; Hansen T; Pedersen O
Diabetologia; 2007 Jun; 50(6):1201-8. PubMed ID: 17431579
[TBL] [Abstract][Full Text] [Related]
14. Protective role of +294 T/C (rs2016520) polymorphism of PPARD in Mexican patients with colorectal cancer.
Rosales-Reynoso MA; Wence-Chavez LI; Arredondo-Valdez AR; Dumois-Petersen S; Barros-Núñez P; Gallegos-Arreola MP; Flores-Martínez SE; Sánchez-Corona J
Genet Mol Res; 2017 Jan; 16(1):. PubMed ID: 28128413
[TBL] [Abstract][Full Text] [Related]
15. Effect of TCF7L2 polymorphism on pancreatic hormones after exenatide in type 2 diabetes.
Ferreira MC; da Silva MER; Fukui RT; do Carmo Arruda-Marques M; Azhar S; Dos Santos RF
Diabetol Metab Syndr; 2019; 11():10. PubMed ID: 30700996
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism of the
Cao Y; Zhang Q; Chen J; Li Z; Zhou Z; Shen J; Wang D; Pan D; Wang Z; Ke D; Wang X; Lu D; Zhao Y; Cheng S; Shi Y
Hereditas; 2019; 156():15. PubMed ID: 31148953
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-delta genotype influences metabolic phenotype and may influence lipid response to statin therapy in humans: a genetics of diabetes audit and research Tayside study.
Burch LR; Donnelly LA; Doney AS; Brady J; Tommasi AM; Whitley AL; Goddard C; Morris AD; Hansen MK; Palmer CN
J Clin Endocrinol Metab; 2010 Apr; 95(4):1830-7. PubMed ID: 20200337
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
Andrulionyte L; Peltola P; Chiasson JL; Laakso M;
Diabetes; 2006 Jul; 55(7):2148-52. PubMed ID: 16804087
[TBL] [Abstract][Full Text] [Related]
19. Association between glucagon-like peptide-1 receptor gene polymorphism and treatment response to GLP1R agonists in Chinese patients with type 2 diabetes: a prospective cohort study.
Guan Z; Du Y; Li R; Zhang S; Xu Y; Zhang X; Zhang F; Yin Y; Wu K; Li X; Li Y
Eur J Clin Pharmacol; 2022 May; 78(5):793-799. PubMed ID: 35079845
[TBL] [Abstract][Full Text] [Related]
20. Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes.
Liu HL; Lin YG; Wu J; Sun H; Gong ZC; Hu PC; Yin JY; Zhang W; Wang D; Zhou HH; Liu ZQ
Eur J Clin Pharmacol; 2008 Jul; 64(7):663-71. PubMed ID: 18438653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
